Rituximab-induced neutropenia in a patient with inflammatory myopathy and systemic sclerosis overlap disease

Rituximab (RTX) is a monoclonal chimeric antibody directed against the CD20 antigen of B lymphocytes. Late onset neutropenia (LON) is a recognised complication of rituximab usually occurring 4 weeks after the last dose and is reported in both haematological and rheumatological conditions. However, i...

Full description

Bibliographic Details
Main Authors: Qasim Akram, Mark Roberts, Chester Oddis, Arianne Herrick, Hector Chinoy
Format: Article
Language:English
Published: Termedia Publishing House 2016-03-01
Series:Rheumatology
Subjects:
Online Access:http://www.termedia.pl/Rituximab-induced-neutropenia-in-a-patient-with-inflammatory-myopathy-and-systemic-sclerosis-overlap-disease,18,27173,1,1.html

Similar Items